Literature DB >> 10945563

Prognostic factors in malignant gastrointestinal stromal tumors.

C A Muro-Cacho1, A B Cantor, M Morgan.   

Abstract

Gastrointestinal stromal tumors are a heterogeneous group of mesenchymal neoplasms of the gastrointestinal tract in which routine histopathological evaluation fails to reveal definitive evidence of differentiation. Given the heterogeneity in clinical presentation and the frequent morphological overlap, the biological behavior of these neoplasms is difficult to predict. We have evaluated, by Cox Proportional Hazards Regression Analysis, the clinicopathological features of 51 malignant gastrointestinal stromal tumors to identify predictors of survival. In the univariate analysis, survival inversely correlated with size, number of mitoses, and patient's age. In the multivariate analysis, only the degree of necrosis and phenotypic differentiation toward smooth muscle were found to be indicators of poor prognosis. Based on these results, a simple classification scheme for gastrointestinal stromal tumors is proposed. This classification appears to have great prognostic value for these tumors, and may be useful in guiding therapeutic management.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10945563

Source DB:  PubMed          Journal:  Ann Clin Lab Sci        ISSN: 0091-7370            Impact factor:   1.256


  6 in total

1.  Surgical margin status and prognosis of gastrointestinal stromal tumor.

Authors:  António M Gouveia; Amadeu P Pimenta; Ana F Capelinha; Dionísio de la Cruz; Paula Silva; José M Lopes
Journal:  World J Surg       Date:  2008-11       Impact factor: 3.352

2.  Alterations of tumor-related genes do not exactly match the histopathological grade in gastric adenocarcinomas.

Authors:  Guo-Yan Liu; Kun-Hong Liu; Yong Zhang; Yu-Zhi Wang; Xiao-Hong Wu; Yi-Zhuo Lu; Chao Pan; Ping Yin; Hong-Feng Liao; Ji-Qin Su; Qing Ge; Qi Luo; Bin Xiong
Journal:  World J Gastroenterol       Date:  2010-03-07       Impact factor: 5.742

Review 3.  Controlling Cancer Cell Death Types to Optimize Anti-Tumor Immunity.

Authors:  Marie Oliver Metzig; Alexander Hoffmann
Journal:  Biomedicines       Date:  2022-04-22

4.  Long-term follow-up in 54 surgically treated patients with gastrointestinal stromal tumours.

Authors:  Konrad Klaus Richter; Constanze Schmid; Mark Thompson-Fawcett; Utz Settmacher; Annelore Altendorf-Hofmann
Journal:  Langenbecks Arch Surg       Date:  2008-03-13       Impact factor: 3.445

5.  Tumor necrosis: A synergistic consequence of metabolic stress and inflammation.

Authors:  Patricia P Yee; Wei Li
Journal:  Bioessays       Date:  2021-05-16       Impact factor: 4.653

6.  Neutrophil-induced ferroptosis promotes tumor necrosis in glioblastoma progression.

Authors:  Patricia P Yee; Yiju Wei; Soo-Yeon Kim; Tong Lu; Stephen Y Chih; Cynthia Lawson; Miaolu Tang; Zhijun Liu; Benjamin Anderson; Krishnamoorthy Thamburaj; Megan M Young; Dawit G Aregawi; Michael J Glantz; Brad E Zacharia; Charles S Specht; Hong-Gang Wang; Wei Li
Journal:  Nat Commun       Date:  2020-10-27       Impact factor: 14.919

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.